open access

Vol 50, No 1 (2019)
Original Research Article / Praca Oryginalna
Submitted: 2019-02-05
Published online: 2019-05-08
Get Citation

Evaluation of the prognostic and predictive value of free light chains in patients with chronic lymphocytic leukemia – preliminary results

Agnieszka Szymczyk1, Aleksandra Nowaczyńska2, Maciej Korpysz3, Helena Donica3, Agnieszka Bojarska-Junak4, Monika Długosz-Danecka5, Waldemar Tomczak26, Ewa Wąsik-Szczepanek2, Iwona Hus1
DOI: 10.2478/ahp-2019-0003
·
Acta Haematol Pol 2019;50(1):15-20.
Affiliations
  1. Department of Clinical Transplantology, Medical University of Lublin, Lublin, Poland
  2. Chair and Department of Haematooncology and Bone Marrow Transplantation, Medical University of Lublin, Lublin, Poland
  3. Department of Biochemical Diagnostics, Medical University of Lublin, Lublin, Poland
  4. Chair and Department of Clinical Immunology, Medical University of Lublin
  5. Department of Hematology, Jagiellonian University Medical College, Krakow, Poland
  6. Chair of Internal Medicine and Department of Internal Medicine in Nursing, Medical University of Lublin, Lublin, Poland

open access

Vol 50, No 1 (2019)
Original Research Article / Praca Oryginalna
Submitted: 2019-02-05
Published online: 2019-05-08

Abstract

Introduction

κ and λ serum free light chains (sFLCs) are produced during physiological lymphopoesis by plasmocytes and B lymphocytes in a constant ratio related to heavy chains. The measurement of sFLC plays an important role in the diagnosis and monitoring of patients with multiple myeloma (MM). The first reports suggested that sFLC disturbances might have prognostic value also in patients with chronic lymphocytic leukemia (CLL). Aim of the study: The aim of the study was to evaluate the relationship between sFLC concentration and recognized prognostic factors and clinical course of CLL. Materials and methods: The sFLC concentration was measured using a latex-enhanced immunoassay in 59 patients with newly diagnosed CLL. The relationship between sFLC concentration and time to start of the treatment (TFT), the response rate to therapy (ORR) and overall survival (OS) was assessed.

Results

A significant correlation was found between sFLC κ concentration and the clinical stage of leukemia according to Rai classification, β-2 microglobulin concentration, LDH activity, CD38 expression, as well as between sFLC λlevel and β-2 microglobulin concentration and platelet count (PLT ). There was also a correlation between the values of summated κ and λ and the clinical stage of disease according to Rai classification, β-2 microglobulin concentration, CD38 expression, white blood cells count (WBC), lymphocyte count (ALC) and hemoglobin (Hgb) concentration. The κ/λ ratio (FCLR) values were significantly different in the CD38+ and CD38- population.

Summary

Simple and reproducible clonality index, which constitutes the sFLC concentration assessment, can be an attractive, potential prognostic marker in patients with CLL, however further studies are needed on a larger group of patients especially in relation to the predictive value of sFLC.

Abstract

Introduction

κ and λ serum free light chains (sFLCs) are produced during physiological lymphopoesis by plasmocytes and B lymphocytes in a constant ratio related to heavy chains. The measurement of sFLC plays an important role in the diagnosis and monitoring of patients with multiple myeloma (MM). The first reports suggested that sFLC disturbances might have prognostic value also in patients with chronic lymphocytic leukemia (CLL). Aim of the study: The aim of the study was to evaluate the relationship between sFLC concentration and recognized prognostic factors and clinical course of CLL. Materials and methods: The sFLC concentration was measured using a latex-enhanced immunoassay in 59 patients with newly diagnosed CLL. The relationship between sFLC concentration and time to start of the treatment (TFT), the response rate to therapy (ORR) and overall survival (OS) was assessed.

Results

A significant correlation was found between sFLC κ concentration and the clinical stage of leukemia according to Rai classification, β-2 microglobulin concentration, LDH activity, CD38 expression, as well as between sFLC λlevel and β-2 microglobulin concentration and platelet count (PLT ). There was also a correlation between the values of summated κ and λ and the clinical stage of disease according to Rai classification, β-2 microglobulin concentration, CD38 expression, white blood cells count (WBC), lymphocyte count (ALC) and hemoglobin (Hgb) concentration. The κ/λ ratio (FCLR) values were significantly different in the CD38+ and CD38- population.

Summary

Simple and reproducible clonality index, which constitutes the sFLC concentration assessment, can be an attractive, potential prognostic marker in patients with CLL, however further studies are needed on a larger group of patients especially in relation to the predictive value of sFLC.

Get Citation

Keywords

chronic lymphocytic leukemia; free light chains; prognostic factors

About this article
Title

Evaluation of the prognostic and predictive value of free light chains in patients with chronic lymphocytic leukemia – preliminary results

Journal

Acta Haematologica Polonica

Issue

Vol 50, No 1 (2019)

Pages

15-20

Published online

2019-05-08

Page views

194

Article views/downloads

228

DOI

10.2478/ahp-2019-0003

Bibliographic record

Acta Haematol Pol 2019;50(1):15-20.

Keywords

chronic lymphocytic leukemia
free light chains
prognostic factors

Authors

Agnieszka Szymczyk
Aleksandra Nowaczyńska
Maciej Korpysz
Helena Donica
Agnieszka Bojarska-Junak
Monika Długosz-Danecka
Waldemar Tomczak
Ewa Wąsik-Szczepanek
Iwona Hus

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., Grupa Via Medica, ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
phone: +48 58 320 94 94, fax: +48 58 320 94 60, e-mail: viamedica@viamedica.pl